Skip to main content
dose.wiki is still in beta. Entries may contain inaccuracies and/or lack citations. See our docs for more info.

2C-T-21

2C-T-21 molecule structure2C-T-21 molecule structure
4-(2-Fluoroethylthio)-2,5-dimethoxyphenethylamine
Aurora
Psychoactive Class

2C-T-21 is a synthetic psychedelic of the substituted phenethylamine class and a member of the 2C-x family.citation needed First described by Alexander Shulgin and colleagues in 1991 and later documented in his book PiHKAL, it was derived from the systematic modification of the mescaline molecule. Distinguished by its fluoroethyl thioether substitution at the 4-position,12 it remains a relatively obscure research chemical with limited documentation regarding its effects and safety profile.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~3 mg
Light3-5 mg
Moderate5-8 mg
Strong8-12 mg
Heavy12+ mg

This substance should only be taken orally. Other routes of administration pose significant risks of serious adverse reactions, including severe nausea and vomiting, dangerous physiological effects, and potentially life-threatening outcomes.

Duration

Onset30-90 minutes
Peak3-4 hours
Offset2-3 hours
After Effects2-4 hours
Total7-12 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

The experience comes on very gradually, typically taking an hour to become noticeable and reaching full intensity by the end of the second hour. It is generally described as a gentle, warm, and non-threatening material characterized by clear thinking, enhanced communication, and a growing sense of closeness with others. Visuals are comparatively subdued, and the compound is repeatedly noted as easy on the body, though higher doses bring a considerable push of energy that can feel restless.

Physical

The body feeling is warm and energetic, generally safe and comfortable, though higher doses produce a push of energy accompanied by restlessness. Chills can occur during onset, along with yawning and ear-popping; appetite effects vary, with decreased appetite reported by some and unusual hunger by others.

Muscle tension

Autonomic

Pupil dilation

Stimulation

Cognitive

The headspace is notably clear and communicative, with empathy, insight, and a softening of the ego rather than dramatic alterations of consciousness. Mood is generally warm and peaceful, though it can occasionally turn faintly grim, and confusion is possible.

Confusion

Emotional

Enhancements

Visual

Visuals are present but understated, described in one account as not too pronounced.

Tactile

See also: Psychedelic Intensity Scale, Effects of psychedelics (visual, cognitive, miscellaneous)

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → orange1
Mecke(ME)
white → purple3
Simons(SI)
orange1 → blue2
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

2C-T-21 acts as a partial agonist at the serotonin 5-HT2A receptor with high affinity (Ki = 27 nM),3 which is believed to underlie its psychedelic effects. It produces the head-twitch response in rodents, a behavioral proxy for psychedelic activity.3 Due to its structural similarity to 2C-T-2 and 2C-T-7, 2C-T-21 is also speculated to possess monoamine oxidase inhibitor (MAOI) properties, though this has not been confirmed.

Pharmacokinetics

Very little data exists regarding the metabolism of 2C-T-21. It has been hypothesized that fluoroacetate, a toxic compound, may be produced as a metabolite.

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

AmphetaminesCocaineDXMTramadol

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

2C-x compounds5-MeO-xxT tryptaminesCannabisDOx compoundsMAOIsMDMAMescalineMXENBOMe compounds
Powered by TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
Develops almost immediately after ingestion.
Baseline Reset
Approximately 7 days in the absence of further consumption
Half Tolerance
Approximately 3 days
Cross Tolerance

Serotonergic psychedelics

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

2C-T-21 is not generally associated with compulsive use; repeated experiences may lessen a person's interest in taking it again. Its use is typically self-limiting.

Toxicity

Multi-organ (Brain, Heart, Lungs, Gonads)

If the hypothesized fluoroacetate metabolite theory is correct, sub-lethal doses may theoretically cause damage to tissues with high metabolic demands; this remains unconfirmed in human studies and should not be assumed to occur at typical doses.

Seizure Risk

A tonic-clonic seizure was documented in the one fatal case, which involved an unknown but presumably very high dose.citation needed These symptoms are consistent with fluoroacetate poisoning. Seizure risk at typical doses (8-12 mg) is unknown due to limited human data.

History & Culture

Discovery and Synthesis

2C-T-21 was first synthesized by Alexander Shulgin, representing the final compound in the 2C-T series to be completed. Shulgin and colleagues first described the substance in scientific literature in 1991,citation needed with detailed documentation appearing in his book PIHKAL (Phenethylamines I

Legality

International

2C-T-21 is not listed in the current official schedules of the 1961 or 1971 conventions or in the 1988 Convention precursor tables.

By Country

Illegal6
Canada flagCanadaIllegal
Germany flagGermanyIllegal
Netherlands flagNetherlandsIllegal (analog/blanket ban)
Norway flagNorwayIllegal
Switzerland flagSwitzerlandIllegal
United Kingdom flagUnited KingdomIllegal
Controlled / restricted1
Austria flagAustriaRestricted
Not scheduled1
United States flagUnited StatesUnscheduled (Analogue Act applies)

References

Source Pages

  1. Erowid
  2. Erowid: 2C-T-21 Experience Vault
  3. Erowid: 2C-T-21 Vault
  4. Isomer Design (TiHKAL/PiHKAL)
  5. PsychonautWiki
  6. TripSit Factsheets
  7. TripSit: Factsheet - 2C-T-21
  8. Wikipedia

Citations

  1. Central nervous system (CNS) activity of two new psychoactive compounds. Journal of Psychoactive Drugs, 23(1), 95–96 (January 1991). https://doi.org/10.1080/02791072.1991.104725831
  2. Shulgin AT, & Shulgin A. (1991). PiHKAL: A Chemical Love Story. Transform Press. https://erowid.org/library/books_online/pihkal/pihkal049.shtml1
  3. Adam L. Halberstadt, Dino Luethi, Marius C. Hoener, Daniel Trachsel, Simon D. Brandt, & Matthias E. Liechti. (January 2023). Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines. Psychopharmacology, 240(1), 115–126. https://doi.org/10.1007/s00213-022-06279-2123
  4. DEA Announces Arrests and Investigation, July 22 2004 (Operation Web Tryp). (n.d.). https://erowid.org/psychoactives/research_chems/research_chems_info1.shtml1
  5. https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/2c-t-21/property/IUPACName,MolecularFormula,MolecularWeight,CanonicalSMILES,IsomericSMILES/JSON. pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/2c-t-21/property/IUPACName,MolecularFormula,MolecularWeight,CanonicalSMILES,IsomericSMILES/JSON1
  6. https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/2c-t-21/synonyms/JSON. pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/2c-t-21/synonyms/JSON1
  7. https://ris.bka.gv.at/GeltendeFassung/Bundesnormen/20007642/NPSV%2c%20Fassung%20vom%2027.08.2026.pdf. ris.bka.gv.at (n.d.). https://ris.bka.gv.at/GeltendeFassung/Bundesnormen/20007642/NPSV%2c%20Fassung%20vom%2027.08.2026.pdf1
  8. https://ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf. ris.bka.gv.at (n.d.). https://ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf1
  9. https://ris.bka.gv.at/GeltendeFassung/Bundesnormen/20007605/NPSG%2c%20Fassung%20vom%2027.08.2026.pdf. ris.bka.gv.at (n.d.). https://ris.bka.gv.at/GeltendeFassung/Bundesnormen/20007605/NPSG%2c%20Fassung%20vom%2027.08.2026.pdf1
  10. https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2011_I_146/BGBLA_2011_I_146.pdf. ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2011_I_146/BGBLA_2011_I_146.pdf1

Further Reading

  1. Brandt SD et al. - Pharmacology of 2C-T compounds (2017)
  2. Nichols DE - Structure-activity relationships of hallucinogenic phenethylamines (2004)

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Lyrea avatar
    Step 2 · First-pass review

    A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 2C-T-21 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.